We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Growing Long-Term Use of LVADs

By HospiMedica staff writers
Posted on 16 Nov 2004
The success of long-term implantable left ventricular-assist devices (LVADs) has led to their increased use in patients previously thought to be unsuitable for mechanical support.

A study published in the September-October 2004 issue of the Journal of Cardiac Surgery documents this shift in the profile of patients in need of artificial hearts to a higher risk group. Researchers looked at the clinical records of 131 consecutive recipients of a LVAD as a bridge-to-transplantation, and found that despite the high-risk status of the patients, the overall mortality rate remained low at 50%. These results could have implications for the funding of artificial heart programs whereby more patients in the high-risk category would be candidates for mechanical assistance.

"The results continue to emphasize that patient selection is the predominant criteria for success in artificial heart programs, but that high-risk patients can be helped in experienced centers,” noted author Dr. Vivec Rao, surgical director of heart transplantation and mechanical circulatory assistance at the Toronto General Hospital.




Related Links:
Toronto General Hospital

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Mammo 3D Performance Kits
Mammo 3D Performance Kits
New
Carotid Artery Stent
Roadsaver

Latest Critical Care News

Breakthrough Technique Stops Irregular Heartbeats

AI Model Accurately Predicts Progression of Autoimmune Disease

AI Predicts and Identifies Subtypes of Type 2 Diabetes from Continuous Blood Glucose Monitor